Literature DB >> 31410174

Ventricular tachycardia and heart failure in a patient of mid-ventricular obstructive hypertrophic cardiomyopathy with apical aneurysm: A case report.

Xin Zhang1, Xingbin Liu1.   

Abstract

Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) with apical aneurysm is a rare type of cardiomyopathy. It is associated with an elevated risk of ventricular arrhythmias, thromboembolism, heart failure and sudden cardiac death. The present case study reports on a patient with MVOHC and apical aneurysm who developed ventricular arrhythmias and heart failure. The patient received an implantable cardioverter defibrillator for prevention of fatal arrhythmias. Ventricular tachycardia was terminated by increased doses of amiodarone and β-blocker. Transthoracic echocardiography indicated a mid-ventricular gradient of 64 mmHg. The patient refused surgical treatment and opted for alcohol septal ablation (ASA). At the 6-month follow-up, a rebound of the gradient following ASA was observed on echocardiography. In the present study, timely recognition of MVOHC with apical aneurysm led to prompt defibrillator implantation for prophylaxis regarding further malignant arrhythmias. Surgical management should be considered in symptomatic patients with MVOHC and apical aneurysm.

Entities:  

Keywords:  apical aneurysm; heart failure; hypertrophic cardiomyopathy; ventricular tachycardia

Year:  2019        PMID: 31410174      PMCID: PMC6676147          DOI: 10.3892/etm.2019.7796

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Clinical implications of midventricular obstruction in patients with hypertrophic cardiomyopathy.

Authors:  Yuichiro Minami; Katsuya Kajimoto; Yutaka Terajima; Bun Yashiro; Dai Okayama; Shintaro Haruki; Takatomo Nakajima; Naomi Kawashiro; Masatoshi Kawana; Nobuhisa Hagiwara
Journal:  J Am Coll Cardiol       Date:  2011-06-07       Impact factor: 24.094

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

3.  Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; John J Finley; J Martijn Bos; Thomas H Hauser; Warren J Manning; Tammy S Haas; John R Lesser; James E Udelson; Michael J Ackerman; Barry J Maron
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

Review 4.  Hypertrophic cardiomyopathy: a systematic review.

Authors:  Barry J Maron
Journal:  JAMA       Date:  2002-03-13       Impact factor: 56.272

5.  Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.

Authors:  H Seggewiss; L Faber
Journal:  Eur J Echocardiogr       Date:  2000-12

Review 6.  Controversies in ventricular remodelling.

Authors:  Lionel H Opie; Patrick J Commerford; Bernard J Gersh; Marc A Pfeffer
Journal:  Lancet       Date:  2006-01-28       Impact factor: 79.321

Review 7.  The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Martin S Maron; E Douglas Wigle; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2009-07-14       Impact factor: 24.094

8.  Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.

Authors:  Georgios K Efthimiadis; Efstathios D Pagourelias; Despoina Parcharidou; Thomas Gossios; Vasileios Kamperidis; Efstratios K Theofilogiannakos; Zoi Pappa; Soultana Meditskou; Stavros Hadjimiltiades; Christodoulos Pliakos; Haralampos Karvounis; Ioannis H Styliadis
Journal:  Circ J       Date:  2013-05-31       Impact factor: 2.993

9.  Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report.

Authors:  Istemihan Tengiz; Ertugrul Ercan; Emin Alioglu; Ugur O Turk
Journal:  BMC Cardiovasc Disord       Date:  2006-04-10       Impact factor: 2.298

10.  Acute failure of catheter ablation for ventricular tachycardia due to structural heart disease: causes and significance.

Authors:  Michifumi Tokuda; Pipin Kojodjojo; Stanley Tung; Usha B Tedrow; Eyal Nof; Keiichi Inada; Bruce A Koplan; Gregory F Michaud; Roy M John; Laurence M Epstein; William G Stevenson
Journal:  J Am Heart Assoc       Date:  2013-05-31       Impact factor: 5.501

View more
  1 in total

1.  Mid-ventricular obstruction is associated with non-sustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy.

Authors:  Changrong Nie; Changsheng Zhu; Minghu Xiao; Qiulan Yang; Yanhai Meng; Rong Wu; Shuiyun Wang
Journal:  Clin Cardiol       Date:  2021-02-24       Impact factor: 2.882

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.